Raghunath Khedkar N, Sindkhedkar M, Joseph A
RSC Med Chem. 2024; 15(5):1626-1639.
PMID: 38784476
PMC: 11110788.
DOI: 10.1039/d4md00055b.
Tomoszkova S, Skarda J, Lipina R
Int J Mol Sci. 2024; 25(8).
PMID: 38674026
PMC: 11050250.
DOI: 10.3390/ijms25084438.
Kannampuzha S, Murali R, Gopalakrishnan A, Mukherjee A, Wanjari U, Namachivayam A
Med Oncol. 2023; 40(11):323.
PMID: 37804361
DOI: 10.1007/s12032-023-02168-6.
Purba E, Saita E, Akhouri R, Ofverstedt L, Wilken G, Skoglund U
Front Endocrinol (Lausanne). 2022; 13:1042787.
PMID: 36531494
PMC: 9748436.
DOI: 10.3389/fendo.2022.1042787.
Mansour S, Adhya I, Lebleu C, Dumpati R, Rehan A, Chall S
Sci Rep. 2022; 12(1):20725.
PMID: 36456600
PMC: 9715707.
DOI: 10.1038/s41598-022-25257-4.
Multifunctional nanocarriers for delivering siRNA and miRNA in glioblastoma therapy: advances in nanobiotechnology-based cancer therapy.
Shetty K, Yasaswi S, Dutt S, Yadav K
3 Biotech. 2022; 12(11):301.
PMID: 36276454
PMC: 9525514.
DOI: 10.1007/s13205-022-03365-2.
MicroRNAs as the critical regulators of cell migration and invasion in thyroid cancer.
Hamidi A, Taghehchian N, Basirat Z, Zangouei A, Moghbeli M
Biomark Res. 2022; 10(1):40.
PMID: 35659780
PMC: 9167543.
DOI: 10.1186/s40364-022-00382-4.
Brain Delivery of Nanomedicines: Trojan Horse Liposomes for Plasmid DNA Gene Therapy of the Brain.
Pardridge W
Front Med Technol. 2022; 2:602236.
PMID: 35047884
PMC: 8757841.
DOI: 10.3389/fmedt.2020.602236.
Hippo Pathway in Regulating Drug Resistance of Glioblastoma.
Casati G, Giunti L, Iorio A, Marturano A, Galli L, Sardi I
Int J Mol Sci. 2021; 22(24).
PMID: 34948224
PMC: 8705144.
DOI: 10.3390/ijms222413431.
Pre-clinical study of human umbilical cord mesenchymal stem cell transplantation for the treatment of traumatic brain injury: safety evaluation from immunogenic and oncogenic perspectives.
Wang G, Wu H, Liu Y, Yan D, Yuan Z, Chen L
Neural Regen Res. 2021; 17(2):354-361.
PMID: 34269210
PMC: 8463980.
DOI: 10.4103/1673-5374.317985.
β-Catenin induces transcriptional expression of PD-L1 to promote glioblastoma immune evasion.
Du L, Lee J, Jiang H, Wang C, Wang S, Zheng Z
J Exp Med. 2020; 217(11).
PMID: 32860047
PMC: 7596815.
DOI: 10.1084/jem.20191115.
Recent Trends of microRNA Significance in Pediatric Population Glioblastoma and Current Knowledge of Micro RNA Function in Glioblastoma Multiforme.
Mazurek M, Grochowski C, Litak J, Osuchowska I, Maciejewski R, Kamieniak P
Int J Mol Sci. 2020; 21(9).
PMID: 32349263
PMC: 7246719.
DOI: 10.3390/ijms21093046.
Phosphofructokinase 1 Platelet Isoform Promotes β-Catenin Transactivation for Tumor Development.
Lee J, Shao F, Ling J, Lu S, Liu R, Du L
Front Oncol. 2020; 10:211.
PMID: 32195176
PMC: 7066116.
DOI: 10.3389/fonc.2020.00211.
Blood-Brain Barrier and Delivery of Protein and Gene Therapeutics to Brain.
Pardridge W
Front Aging Neurosci. 2020; 11:373.
PMID: 31998120
PMC: 6966240.
DOI: 10.3389/fnagi.2019.00373.
Differential gene expression analysis of HNSCC tumors deciphered tobacco dependent and independent molecular signatures.
Shaikh I, Ansari A, Ayachit G, Gandhi M, Sharma P, Bhairappanavar S
Oncotarget. 2019; 10(58):6168-6183.
PMID: 31692905
PMC: 6817442.
DOI: 10.18632/oncotarget.27249.
Brexpiprazole, a Serotonin-Dopamine Activity Modulator, Can Sensitize Glioma Stem Cells to Osimertinib, a Third-Generation EGFR-TKI, via Survivin Reduction.
Suzuki S, Yamamoto M, Sanomachi T, Togashi K, Sugai A, Seino S
Cancers (Basel). 2019; 11(7).
PMID: 31284441
PMC: 6679129.
DOI: 10.3390/cancers11070947.
Molecular Neuropathology in Practice: Clinical Profiling and Integrative Analysis of Molecular Alterations in Glioblastoma.
Nasrallah M, Binder Z, Oldridge D, Zhao J, Lieberman D, Roth J
Acad Pathol. 2019; 6:2374289519848353.
PMID: 31206012
PMC: 6537274.
DOI: 10.1177/2374289519848353.
Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery.
Kowalski P, Rudra A, Miao L, Anderson D
Mol Ther. 2019; 27(4):710-728.
PMID: 30846391
PMC: 6453548.
DOI: 10.1016/j.ymthe.2019.02.012.
Identification of antiproliferative emodin analogues as inhibitors of epidermal growth factor receptor in cancer.
Chen K, Juang S, Lien J
Int J Mol Med. 2019; 43(3):1281-1288.
PMID: 30664170
PMC: 6365047.
DOI: 10.3892/ijmm.2019.4066.
Development of a Novel EGFR-Targeting Antibody-Drug Conjugate for Pancreatic Cancer Therapy.
Li Z, Wang M, Yao X, Luo W, Qu Y, Yu D
Target Oncol. 2019; 14(1):93-105.
PMID: 30635821
DOI: 10.1007/s11523-018-0616-8.
